Penn scientists conducted research showing that a CAR-T gel treatment has the potential to kill residual cancer cells left over from surgery.
In the study, Penn scientists added CAR-T cells to a gel designed to prevent bleeding after surgery and applied it to the surgical wounds of mice after they had hard-to-treat tumors resected.
This treatment prevented recurrence in 19 of the mice, and did not result in any side effects or interfere with healing. Now, the therapy is on its way to being tested in humans. Learn more here.